Insurance must cover Bioidentical hormones as they do pharmaceutical one
H To House Finance
Email me when HB 4075 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 4075. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill mandates that any health insurance policy issued on or after Jan. 1, 2026 must pay for bioidentical hormone therapy when a licensed physician determines it is medically necessary. It applies to group accident and sickness plans, health‑care corporations, hospital service corporations, and health‑maintenance organizations, expanding coverage to patients who need these hormones.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 4075
3 free questions a day, no accountHistory
- To House Finance
- To Finance then Judiciary
- Introduced in House
- Filed for introduction
Sponsors
- Crouse · sponsor
- Howell, T.
- White
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 4075 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 4075 freeOr ask your AI assistant about HB 4075 directly:
Add to Claude, ChatGPT or Cursor